Advaxis Inc (ADXS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9 DEER PARK DRIVE MONMOUTH JUNCTION, NJ 08852

Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based strains are believed to be a significant advancement in immunotherapy as they integrate multiple functions into a single immunotherapy and are designed to access and direct antigen presenting cells to stimulate anti-tumor T cell immunity, activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable T cells to eliminate tumors.

Data as of 2021-07-19 08:46:20 -0400
Market Cap64.256 Million Shares Outstanding145.638 Million Avg 30-day Volume13.431 Million
P/E Ratio-3.0064 Dividend Yield EPS-0.252
Price/Sales21.49 Debt to Equity1.17 EBITDA-20.773 Million
Price to Book Value1.35 Forward PE0.27 Enterprise Value16.146 Million
Total Cash48.11 Million Current Debt8.22 Million Gross Profit2.99 Million
BETA0.94723 52-week High/Low1.57 / 0.2639 Next Earnings Date2021-09-09 Price to Cash FLow (P/CF) -16.0838
Data provided by IEX Cloud
View SEC Filings from ADXS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 39 39 0.0% 7 (0.41%) 9 (0.52%) -22.22%
13F shares: 10.022 Million 10.953 Million -8.5% 3.838 Million 7.565 Million -49.27%
% Ownership 8.3892 9.9733 -15.88% 3.2123 6.8889 -53.37%
New Positions: 8 11 -27.27% 2
Increased Positions 12 9 33.33% 4 5 -20.0%
Closed Positions 8 2 300.0% 2 1 100.0%
Reduced Positions 8 5 60.0% 2 1 100.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ADXS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADXS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GITELMAN IGOR CHIEF ACCOUNTING OFFICER

  • Officer
0 2021-02-11 1

BERMAN RICHARD J

  • Director
0 2020-05-04 0

APPEL RONI

  • Director
0 2020-05-04 0

PATTON JAMES P

  • Director
0 2020-05-04 0

SIDRANSKY DAVID

  • Director
0 2020-05-04 0

KHLEIF SAMIR N

  • Director
0 2020-05-04 0

GUTIERREZ ANDRES EXECUTIVE VICE PRESIDENT & CMO

  • Officer
0 2020-05-04 0

BERLIN KENNETH A PRESIDENT AND CEO

  • Officer
0 2020-05-04 0

HENDERSON MOLLY EXECUTIVE VICE PRESIDENT & CFO

  • Officer
0 2020-05-04 0

PETIT ROBERT CHIEF SCIENTIFIC OFFICER

  • Officer
231,206 2018-11-05 0

LOMBARDO ANTHONY A INTERIM CEO

  • Officer
81,852 2018-04-17 0

BONSTEIN SARA CHIEF FINANCIAL OFFICER

  • Officer
226,670 2018-03-29 0

MCKEARN THOMAS J

  • Director
0 2017-11-02 0

RIDGE THOMAS J

  • Director
0 2017-11-02 0

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2017-10-11 0

O'CONNOR DANIEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
618,352 2017-06-30 0

MAYES, GREGORY T.

  • Director
103,841 2016-12-30 0

MAURO DAVID J CHIEF MEDICAL OFFICER

  • Officer
166,271 2015-12-31 0

FRENCH CHRISTY LEE VP-REGULATORY, MEDICAL AFFAIRS

  • Officer
71,938 2014-12-31 0

MOORE THOMAS A

  • FORMER DIRECTOR
176,462 2014-07-17 0

ROSENBLUM MARK J CHIEF FINANCIAL OFFICER

  • Officer
113,774 2014-01-31 0

ROTHMAN JOHN F EXEC VP OF SCIENCE AND OPS

  • Officer
0 2011-11-08 0

COBB FREDRICK D VICE PRESIDENT FINANCE

  • Officer
0 2009-07-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ADVAXIS INC ADXS 2021-07-23 22:15:03 UTC -3.3926 3.4726 800000
ADVAXIS INC ADXS 2021-07-23 21:45:03 UTC -3.3926 3.4726 800000
ADVAXIS INC ADXS 2021-07-23 21:15:03 UTC -3.3926 3.4726 800000
ADVAXIS INC ADXS 2021-07-23 20:45:03 UTC -3.3884 3.4684 800000
ADVAXIS INC ADXS 2021-07-23 20:15:05 UTC -3.3884 3.4684 800000
ADVAXIS INC ADXS 2021-07-23 19:45:03 UTC -3.3884 3.4684 800000
ADVAXIS INC ADXS 2021-07-23 19:15:03 UTC -3.3884 3.4684 600000
ADVAXIS INC ADXS 2021-07-23 18:45:03 UTC -3.3884 3.4684 600000
ADVAXIS INC ADXS 2021-07-23 18:15:03 UTC -3.3884 3.4684 600000
ADVAXIS INC ADXS 2021-07-23 17:45:03 UTC -3.3884 3.4684 600000
ADVAXIS INC ADXS 2021-07-23 17:15:02 UTC -3.3884 3.4684 600000
ADVAXIS INC ADXS 2021-07-23 16:45:02 UTC -3.6121 3.6921 600000
ADVAXIS INC ADXS 2021-07-23 16:15:03 UTC -3.6121 3.6921 600000
ADVAXIS INC ADXS 2021-07-23 15:45:02 UTC -3.6121 3.6921 600000
ADVAXIS INC ADXS 2021-07-23 15:15:03 UTC -3.6121 3.6921 600000
ADVAXIS INC ADXS 2021-07-23 14:45:03 UTC -3.3884 3.4684 600000
ADVAXIS INC ADXS 2021-07-23 14:15:03 UTC -3.3884 3.4684 150000
ADVAXIS INC ADXS 2021-07-23 13:45:03 UTC -3.3884 3.4684 150000
ADVAXIS INC ADXS 2021-07-23 13:15:03 UTC -3.3884 3.4684 150000
ADVAXIS INC ADXS 2021-07-23 12:45:03 UTC -3.3884 3.4684 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ADXS -30100.0 shares, $-22159.62 2021-03-31 N-PORT

Elevate your investments